| Structure |
Chemical Name |
CAS |
MF |
 |
Rocuronium Bromide Impurity 24 、25 |
|
|
|
|
Roxadustat Impurity 17 |
|
|
|
|
Perospirone Impurity 20 |
1002359-81-0 |
|
|
|
Dolutegravir Impurity 19 |
|
|
|
|
Cephalexin Impurity I |
|
|
|
|
Fondaparinux sodium impurity 6 |
|
|
|
|
Fondaparinux sodium impurity 2 |
|
|
|
|
Oxacillin sodium Impurity I |
|
|
|
|
Mixture of Cefoxitin Impurity E&F |
|
|
|
|
Revefenacin Impurity 22 |
|
|
|
|
Lasmiditan Impurity 7 |
|
|
|
|
Febuxostat impurity BAC |
|
|
 |
4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENOL |
866018-46-4 |
C16H14Cl2O |
|
|
Lasmiditan Impurity 9 |
|
|
|
|
Letermovir Impurity 2 |
|
|
 |
1H-イミダゾール-2-カルボン酸 |
16042-25-4 |
C4H4N2O2 |
|
|
Olodaterol Impurity 19 |
|
|
|
|
Ethacridine Impurity 12 |
|
|
 |
Indacaterol Impurity 3 |
2250243-41-3 |
C26H32N2O3 |
|
|
Canagliflozin Impurity 11 |
|
|
|
|
Oseltamivir Impurity 22 |
|
|
|
|
Riociguat IMpurtiy B |
|
|
|
|
Silodosin Impurity C |
|
|
 |
Dexmedetomidine-025 |
2250242-52-3 |
C20H22N2 |
|
|
pranoprofen impurity 15 |
|
|
 |
Mono-Hydroxy Sugammadex |
2376607-99-5 |
C69H109NaO47S7 |
|
|
Metronidazole impurity A |
|
|
|
|
Sulpiride Impurity 6 |
|
|
|
|
Cefminox Impurity A |
|
|
|
|
Cefminox Impurity F |
|
|
![IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)](/CAS/20180808/GIF/748812-53-5.gif) |
IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE) |
748812-53-5 |
C25H30N6O2 |
 |
フェノフィブリン酸1,1-ジメチル-2-(1-メチルエトキシ)-2-オキソエチルエステル |
217636-48-1 |
C24H27ClO6 |
 |
(S-(R* S*))-(+)-N-(1-PHENYLETHYL)-1- AZ& |
120570-09-4 |
C15H24Cl2N2 |
![Verapamil Related Compound B (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride)](/CAS/GIF/1794-55-4.gif) |
Verapamil Related Compound B (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride) |
1794-55-4 |
C26H37ClN2O4 |
 |
N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate |
155913-32-9 |
C32H44NO8.C6H5O3S |
![[2R,2'S,αS,α'S,(-)]-α,α'-[イミノビス(メチレン)]ビス(6-フルオロ-3,4-ジヒドロ-2H-1-ベンゾピラン-2-メタノール)](/CAS/GIF/118457-16-2.gif) |
[2R,2'S,αS,α'S,(-)]-α,α'-[イミノビス(メチレン)]ビス(6-フルオロ-3,4-ジヒドロ-2H-1-ベンゾピラン-2-メタノール) |
118457-16-2 |
C22H25F2NO4 |
 |
5-Hydroxymethyl Flucloxacillin |
75524-31-1 |
C19H17ClFN3O6S |
 |
6-ヒドロキシ-5-メトキシ-1-インダノン |
90843-62-2 |
C10H10O3 |
 |
デホルミルビンクリスチン |
18172-50-4 |
C45H56N4O9 |
 |
ラベプラゾールスルホン |
117976-47-3 |
C18H21N3O4S |
 |
6-ブロモ-3H-イソベンズオフラン-1-オン |
19477-73-7 |
C8H5BrO2 |
 |
TOPOTECANACETATE |
123948-88-9 |
C25H27N3O7 |
 |
dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarb oxylate |
21829-09-4 |
C17H18N2O6 |
 |
Metronidazole IMpurity (1-Methyl-4-Nitro-1H-IMidazole) |
143508-97-8 |
C2H3NO |
 |
(S)-Phenylephrine hydrochloride |
939-38-8 |
C9H14ClNO2 |
 |
L-erythro-3-(3,4-Dihydroxyphenyl)serine |
34047-62-6 |
C9H11NO5 |
 |
2-(メチルエチルアミノ)-N-(2,6-ジメチルフェニル)アセトアミド |
74634-66-5 |
C13H20N2O |
 |
リボフラビン3′,5′-ビスりん酸 |
86108-26-1 |
C17H22N4O12P2 |
 |
6 beta-hydroxycortisol |
53-35-0 |
C21H30O6 |
 |
16-hydroxyclarithromycin |
124412-58-4 |
C38H69NO14 |
 |
ビス(P-アセチルアミノフェニル)エーテル |
3070-86-8 |
C16H16N2O3 |
 |
3-(2-hydroxyethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
85677-95-8 |
C18H20N2O7 |
 |
3-isobutylisobenzofuran-1(3H)-one |
199736-94-2 |
C12H14O2 |
![isopropyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20200401/GIF/625115-54-0.gif) |
isopropyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-54-0 |
C22H23FN8O2 |
 |
Epalrestat iMpurity |
109801-00-5 |
C13H18O |
 |
5-Oxo Pitavastatin |
222306-15-2 |
C25H22FNO4 |
 |
(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one |
1312077-05-6 |
C12H11NO |
 |
2-Hydroxy Cephalexin |
215172-75-1 |
C16H17N3O5S |
 |
3-(9H-Carbazol-4-yloxy)-1,2-propanediol |
123119-89-1 |
C15H15NO3 |
 |
4-(2-Methylpropoxy)-1,3-benzenedicarbothioaMide |
1330632-46-6 |
C12H16N2OS2 |
 |
9-MethoxyMethyl Guanine |
1202645-50-8 |
C7H9N5O2 |
 |
1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride |
|
C24H38Cl2N4O4S2 |
 |
Mupirocin iMpurity 5 |
|
C26H44O9 |
 |
Tolvaptan Impurity 11 |
150683-27-5 |
C25H23ClN2O3 |
 |
methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate |
1638785-19-9 |
C13H15ClO3 |
 |
1155863-81-2 |
1155863-81-2 |
C23H19F2N3O6 |
 |
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
 |
Clopidogrel Impurity 44 |
|
C15H14ClNO2S |
![5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate](/CAS/20200331/GIF/949155-13-9.gif) |
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
 |
Nifedipine impurity 06 |
|
C19H22N2O6 |
|
|
Moxifloxacin Impurity 10 |
|
|
|
|
Ticagrelor Impurity 11 |
|
|
|
|
Parecoxib Impurity 18 |
|
|
|
|
Teneligliptin Impurity 9 DiHCl |
|
|
|
|
Pramipexole Impurity Z2 |
|
|
 |
1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl- |
962-95-8 |
C17H22NOP |
 |
Cabozantinib Impurity 50 |
202917-05-3 |
C17H14N2O5 |
|
|
Landiolol impurity U |
|
|
 |
Fondaparinux sodium impurity 8 |
2088176-32-1 |
C30H50N2O46S7 |
|
|
Fondaparinux sodium impurity 14 |
|
|
|
|
Fondaparinux Sodium Impurity 9 |
|
|
|
|
Oxacillin sodium Impurity D |
|
|
|
|
Piracetam IMPURITY |
|
|
|
|
Nilotinib N-Oxide Impurity 4 |
|
|
|
|
sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
|
|
Olodaterol Impurity 32 |
|
|
 |
(R)-Lercanidipine Hydrochloride |
187731-34-6 |
C36H42ClN3O6 |
 |
2-Oxo Clopidogrel Hydrochloride (Mixture of diastereomers) |
109904-27-0 |
C16H16ClNO3S |
 |
5-ヒドロキシ-6-メトキシ-1-インダノン |
127399-78-4 |
C10H10O3 |
 |
Desfluoro Citalopram Oxalate |
1093072-86-6 |
C22H24N2O5 |
 |
Didesmethyl Zolmitriptan |
139264-15-6 |
C14H17N3O2 |
 |
1-(カルボキシメチル)シクロヘキサン-1-カルボン酸 |
67950-95-2 |
C9H14O4 |
 |
ヒドロキシボセンタン |
253688-60-7 |
C27H29N5O7S |
![LISINOPRIL RELATED COMPOUND A ((S)-2-{(3S,8AS)-3-(4-AMINOBUTYL)-1,4-DIOXOHEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YL}-4-PHENYLBUTANOIC ACID)](/CAS/GIF/328385-86-0.gif) |
LISINOPRIL RELATED COMPOUND A ((S)-2-{(3S,8AS)-3-(4-AMINOBUTYL)-1,4-DIOXOHEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YL}-4-PHENYLBUTANOIC ACID) |
328385-86-0 |
C21H29N3O4 |
 |
trans 1-Benzyl-4-(4-fluorophenyl)-3-piperidinemethanol |
201855-60-9 |
C19H22FNO |
 |
1-エチル-4-オキソ-6-フルオロ-7-クロロ-1,4-ジヒドロキノリン-3-カルボン酸エチル |
70458-94-5 |
C14H13ClFNO3 |
|
|
Capecitabine Related Compound B |
|
|
 |
D-erythro-3,4-Dihydroxyphenylserine |
51829-98-2 |
C9H11NO5 |
 |
aztreonam |
80951-91-3 |
C13H17N5O8S2 |
![5H-[1]Benzopyrano[2,3-b]pyridine,7-ethyl-(9CI)](/CAS/20200515/GIF/639857-68-4.gif) |
5H-[1]Benzopyrano[2,3-b]pyridine,7-ethyl-(9CI) |
639857-68-4 |
C14H13NO |